Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
We have a wide range of fun and festive designs to choose from. Fund life changing research while spreading joy this Christmas!
This Christmas, your gift can bring us closer to a cure for type 1 diabetes – and every pound you give to our Christmas Appeal will be doubled.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This event is designed for anyone living with type 1 diabetes who would like to learn more about managing their wellbeing across a variety of contexts.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > About JDRF & Our Impact > Our research > Research projects > A digital psychosocial wellbeing tool for young people with type 1
Best practice guidelines recommend that psychosocial screening should be a routine part of diabetes healthcare. But we don’t have an effective way for HCPs to assess and monitor the wellbeing of people with type 1. The assessment tools currently used are often time-consuming, inaccurate, and unempowering, which has led to a gap in psychosocial support for young people with type 1. So, this research project is crucial to develop a more effective way to assess, monitor and support mental health in young people with type 1.
First, the Emma will work with a digital health company to deliver a series of Patient and Public Involvement (PPI) workshops to create the digital psychosocial wellbeing tool. Young people living with type 1, their caregivers and diabetes clinicians will all be invited to the workshops. This group will help to shape the content features, information, and appearance of the tool, including the name and branding. Then, the company will develop prototypes of the tool and present it to the researchers and the people who attended the workshops. Using the collective feedback, the digital company will create the first version of the tool.
Once the digital psychosocial wellbeing tool is complete, the researchers need to evaluate its usefulness and practicality as part of routine diabetes care. To do this, Emma will invite around 20 people with type 1 aged 13-18 years who attend a paediatric diabetes clinic in Northern Ireland to help her test the tool. She will encourage the young people (or their guardians) who agree to take part to complete the tool before their next standard diabetes clinic or annual review appointment.
The selections the young people make and the information they add to their digital tool profile will provide an overview of their psychosocial wellbeing at that point in time and enable them and their caregivers to track changes and progress. This overview of psychosocial wellbeing will be used to guide conversations during upcoming diabetes appointments, reflecting on any change and progress.
Emma’s research team will collect and analyse data on how the young people and HCPs engaged with the digital tool. The researchers will also gather feedback on how easy, valuable and useful the young people with type 1 thought the tool was. Emma will use this information to help her develop a follow-up research project to continue evaluating the tool to optimise it for a paediatric diabetes service.
The aim of the project is to provide a more resourceful method of assessing and monitoring the psychosocial wellbeing of young people with type 1. If the digital psychosocial wellbeing tool proves useful and effective, it will enable young people to share their needs and voices and feel more empowered to shape appointments with their diabetes healthcare team. Improving communication between people with type 1 and their HCPs about psychosocial wellbeing is the first step to improving wellbeing through targeted support.
Daniel Doherty’s research project aims to make islet transplants last longer and work better to benefit more people with type 1.
Lead researcher, Kourosh, says his study has the potential to transform our understanding of diabetes.
Dr Leslie Johnson will explore whether a collaborative care model that is effective for type 2 diabetes can be adapted for people with type 1.
Dr Chloe Rackham is investigating how supportive cells called mesenchymal stem cells may help protect people from developing type 1.